David is a professional with extensive experience in the pharmaceutical industry including experience in drug discovery and development, drug metabolism, disposition, structure identification, mass spectrometry imaging, technology development. David graduated with a BS in Chemistry from University of Michigan and went on to earn a doctorate degree in from Michigan State University. He began his career at Glaxo where he held positions throughout research and development including proteomics, combinatorial chemistry, technology development and DMPK. David was instrumental in introducing mass spectrometry imaging in GSK and technology development. David joined AbbVie in 2018 as the Director of Drug Metabolism and Distribution within DMPK department. He has been leading the effort of establishing MS imaging in AbbVie and building a group to deliver impact for distribution studies.